1. Home
  2. TARA vs SKYX Comparison

TARA vs SKYX Comparison

Compare TARA & SKYX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Protara Therapeutics Inc.

TARA

Protara Therapeutics Inc.

N/A

Current Price

$5.71

Market Cap

268.5M

Sector

Health Care

ML Signal

N/A

Logo SKYX Platforms Corp.

SKYX

SKYX Platforms Corp.

N/A

Current Price

$1.94

Market Cap

292.8M

ML Signal

N/A

Company Overview

Basic Information
Metric
TARA
SKYX
Founded
N/A
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Building Products
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
268.5M
292.8M
IPO Year
2014
2014

Fundamental Metrics

Financial Performance
Metric
TARA
SKYX
Price
$5.71
$1.94
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
8
3
Target Price
$21.86
$5.00
AVG Volume (30 Days)
1.1M
809.7K
Earning Date
06-18-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
38.25
20.00
EPS
N/A
N/A
Revenue
$2,948,000.00
$7,700,948.00
Revenue This Year
N/A
$9.10
Revenue Next Year
N/A
$26.56
P/E Ratio
N/A
N/A
Revenue Growth
N/A
9.78
52 Week Low
$2.77
$0.88
52 Week High
$7.82
$3.29

Technical Indicators

Market Signals
Indicator
TARA
SKYX
Relative Strength Index (RSI) 43.53 42.30
Support Level $4.87 $0.96
Resistance Level $5.77 $2.44
Average True Range (ATR) 0.54 0.12
MACD -0.10 -0.00
Stochastic Oscillator 17.27 33.60

Price Performance

Historical Comparison
TARA
SKYX

About TARA Protara Therapeutics Inc.

Protara Therapeutics Inc is committed to identifying and advancing transformative therapies for people with cancer and rare diseases. The company discovers, develops and delivers breakthrough therapies to people who have limited treatment options. Its portfolio includes its program, TARA-002, being developed for the treatment of lymphatic malformations, and intravenous (IV) choline chloride, a phospholipid substrate replacement therapy for the treatment of intestinal failure associated liver disease (IFALD).

About SKYX SKYX Platforms Corp.

SKYX Platforms Corp operates in the business of developing proprietary technology that enables a quick and safe installation of electrical fixtures, such as light fixtures and ceiling fans. Its technology consists of a weight-bearing, fixable socket and a revolving plug for conducting electric power and supporting an electrical appliance attached to a wall or ceiling. The socket is comprised of a nonconductive body that houses conductive rings connectable to an electric power supply through terminals in its side exterior. The plug is also comprised of a nonconductive body that houses corresponding conductive rings, attaches to the socket via a male post, and is capable of feeding electric power to an appliance. It generates its income from lighting and heating products sold in the USA.

Share on Social Networks: